Downloads provided by UsageCounts
handle: 10261/28587 , 10261/40852
Nucleósidos modificados para el tratamiento de infecciones por Leishmania. Compuestos derivados de nucleósidos y su uso para el tratamiento de enfermedades infecciosas causadas por Leishmania. Además la invención se refiere a las composiciones farmacéuticas que contienen dichos compuestos.
Consejo Superior de Investigaciones Científicas (España), Universidad de Alcalá
B1 Patente sin examen previo
Peer reviewed
Leishmania, Infecciones, Composiciones farmacéuticas, Patente, Enfermedades infecciosas, Nucleósidos, Compuestos derivados de nucleósidos
Leishmania, Infecciones, Composiciones farmacéuticas, Patente, Enfermedades infecciosas, Nucleósidos, Compuestos derivados de nucleósidos
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 41 | |
| downloads | 74 |

Views provided by UsageCounts
Downloads provided by UsageCounts